One such mechanism may relate to the ability of resistant cells to evade drug-induced cell death due to activation of anti-apoptotic mechanisms [35]; co-deregulation of ABCB1 and apoptotic proteins was previously shown to correlate with a multifactorial resistant phenotype in cancer cells [11,36]. Here, ABCB1 is linked to cancer.